Upload
hadang
View
214
Download
0
Embed Size (px)
Citation preview
CM 0)r- tn
6 ""
IGC-1231991
Peview of Literature on Bioassay MethodsFor Estimating Radionuclides in Urine
M.V.R. Prasad
D.S. Surya NarayanaR.K. Jeevanram
A.R. Sundararajan
GOVERNMENT OF INDIA. DEPARTMENT OF ATOMIC ENERGY
INDIRA GANDHI CENTRE FOR ATOMIC RESEARCH KALPAKKAM
JG-C —
1991
GOVERNMENT OF INDIA
DEPARTMENT OF ATOMIC ENERGY
REVIEW OF LITERATURE ON BIOASSAY METHODS FOR ESTIMATING
RADIONUCLIDES IN URINE
M.V.R. PRASAD, D.S. SURYA NARAYANA, R.K. JEEVANRAM AND
A.R. SUNDARARAJAN
INDIRA GANDHI CENTRE FOR ATOMIC RESEARCH
KALPAKKAM - 603 102
TAMIL NADU, INDIA
REVIEW OF LITERATURE ON BIOASSAY METHODS FOR ESTIMATING
RADIONUCLIDES IN URINE*
A B S T R A C T
Bioassay methods of c e r t a i n important r a d i o n u c l i d e s
encountered in the n u c l e a r fuel cycle o p e r a t i o n s , v i z . , thor ium,
uranium, Pu-239, Am-241, S r -90 , Tc-99, Ru-106, Cs-137 a r e
reviewed, with spec i a l emphasis on u r i n a l y s i s . Since the
preconcentrat ion is an important prerequisite for bioassay,
various preconcentration methods are also discussed. Brief
account of various instruments both nuclear and analytical used
in the bioassay programme is included. The sens i t iv i t ies of the
methods cited in the l i t e ra ture vis-a-vis the derived recording
levels indicated in ICRP recommendations are compared. Literature
surveyed up to 1990 is tabulated (96 references).
(Key Words: Urinalysis, Bioassay, Preconcentration Methods,
Thorium, Uranium, Pu-239, Am-241, Sr-90, Tc-99, Ru-106, Cs-137)
This report forms part of doctoral work of Sri M.V.R. Prasad tobe submitted to University of Madras.
CONTENTS
1 . INTRODUCTION .. 1
2. BIOASSAY .. 2
2.1. Radionuclide Biokinetics .. 4
2.1.1. Ingestion .. 4
2.1.2 . Inhalation . . 5
2 .1 .3 . Absorption . . 6
2.2. Objectives of Bioassay Programme . . 6
2 . 2 . 1 . Evaluation of Internal Deposition . . 6
2.2 .2 . Evaluation of Control Procedures . . 7
2 .2 .3 . Improved Metabolic Data . . 7
2.3 . Bioassay Techniques . . 8
2.3.1 In-vivo Measurement . . 8
2.3.2 In-vit ro Measurement . . 9
2 . 3 . 2 . 1 . Urine Analysis . . 9
2 .3 .2 .2 . Sampling of Urine ..12
2 .3 .2 .3 . Feces Analysis ..14
2.3 .2 .4 . Blood Analysis ..15
2 .3 .2 .5 . Breath Analysis ..16
2.4. Frequency of Monitoring ..16
3 . PRECONCENTRATION METHODS . . 1 7
3.1. Solvent Extraction ..18
3.1.1. Extraction using chelates ..18
3.2 Extraction Chromatography ..18
3.3 Sorption Methods ..19
3.3.1. Synthetic Ion Exchangers ,.21
3.4. Co-precipitation of Trace Elements ..21
3.4.1. Collectors (carriers) ..22
3.4.2. Inorganic Co-precipitants ..23
3.4.3. Organic Co-precipitants ..24
3.5 Electrochemical Methods ..24
3.5.1. Electrodeposition ..25
4. INSTRUMENTATION ..26
5. ICRP RECOMMENDATIONS FOR INTERNAL DEPOSITION OF
RADIONUCLIDES ..27
5.1. Annual Limit on Intake ..28
5.2. Derived Investigation and Derived recording
levels ..29
6. CONCLUSIONS ..29
7. ACKNOWLEDGEMENTS -.30
8. REFERENCES -.31
1. INTRODUCTION
Indira Gandhi Centre for Atomic Research is a unit of the
Department of Atomic Energy engaged in carrying out Research and
Development activities with special emphasis on the science and
technology related to fast breeder reactors. Some of the
installed facilities which handle radioactive materials include:
Fast Breeder Test Reactor, Radiochemistry Programme, Reprocessing
Development, Centralised Waste Management Facility, and Safety
Research & Health Physics Programme. All safety precautions are
taken in the design and operation of these facilities which
handle the radionuclides associated with the fuel and the fission
products. In spite of good laboratory design, working facilities,
discipline, special training of the staff and planned working
procedures, contamination do occur and spread to many unsuspected
places either due to accidents or otherwise. This results in the
possibility of uptake of the contaminants by radiation workers
through inhalation or ingestion Safety Research & Health Physics
Programme (SRSHPP) of the Centre is entrusted with the
responsibility of conducting effective surveillance on all
radiation workers to ensure safe working conditions. As part of
this surveillance programme, bioassay group of SR&HPP carries out
urine analysis regularly on all radiation workers of the Centre
for radionuclies such as natural thorium, natural uranium, Pu-
239, Am-241, Sr-90, Ru-106, Cs-137 etc. and feces analysis in
certain exposure cases. The methods presently used for estimating
radionuclid as such as plutonium, thorium and uranium, are time
consuming and lack s e n s i t i v i t y . The bioassay group has undertaken
a programme to develop newer methods and/or improve the exis t ing
methods in order to reduce the time and also to improve the
s e n s i t i v i t y of de tec t ion . Recommendations contained in ICRP-54
demand substant ia l increase in the s e n s i t i v i t y of de tec t ion . This
report therefore , reviews the exis t ing methods avai lab le in
l i t e r a t u r e and discusses in de ta i l the importance of bioassay
with special reference to u r ina ly s i s in the in te rna l dosimetry
programme (See Table 1 ) . Since preconcentrat ion methods and
select ion of su i tab le instrumentation are very important steps to
determine the radionuclides in Bioassay methods, sa l ient aspects
of preconcentrat ion and instrumentation ere also discussed in
th i s report .
2. BIOASSAY
Chemical elements present in various biological matrices can
be bas ica l ly grouped in to three ca tegor ies : major elements
consist ing of carbon, hydrcgen, n i t rogen, and oxygen; minor
elements comprising calcijm, chlor ine , magnesium, pnosphorous,
potassium, and sodium; a.id t race elements encompassing the
remainder ' . Bas ica l ly , t'ie major elements act as s t ruc tura l
components while the minor elements maintain the e l ec t ro ly t e
balance to keep the e n t i r e system v i a b l e . The rnaj cr and minor
groups of elements make up most of the body, while a l l the t race
elements combined account for less then 1.% of the t o t a l . Elements
whose concentration l e v e l s fa l l below a few pa r t s per mill ion
are normally regarded as t r a c e s .
Trace elements may be classified into two groups: the
essential and the nonessential. Among the numerous trace
elements, arsenic, chromium, cobalt, copper, fluorine, iodine,
iron, manganese, molybdenum, nickel, selenium, silicon, tin,
vanadium, and zinc are currently considered to be essential for
humans whereas cadmium, mercury, lead and thallium, are non-
essential and known to impair health. Specific elements say,
beryllium, silicon etc., are regarded as industrial hazards.
Elements such as uranium, thorium, transuranics and fission
products released from nuclear reactors are also non-essential
and form a group called radioactive contaminants. On account of
the radioactivities associated with these elements, they pose a
different kind of problem viz., radiation hazards.
The main objective of bioassay is to assure adequate
assessment of occupational workers against the toxic metal ions
that might enter the body. Applications of bioassay are not
limited to radionuclides . They are commonly found in occupational
health programmes dealing with metals (e.g. lead, mercury), and
other industrial chemicals (e.g. fluoride). The normally used
bioassay methods for detecting an internal deposition involve
indirect measurements of either the intake or organ/tissue
burden. However, the bioassay of radioactive materials involves
the measurement of their biological hazards due to their
chemically toxic nature and also the radiation dose they impart
to the orgar.s where they are deposited. Therefore the bioassay of
radioactive materials merits special attention and requires the
understanding of the movement and distribution of metal ions in
the biological systems and also the nature of the decay process
of each nuclide .
2.1. Radi onuclide Biokinet ics
Radionuclides can gain access to the interior of the body
by ingestion, by inhalation, through wounds or by absorption
4through skin as indicated by large arrows in Fig. 1. The
subsequent internal distribution of the radioactive material,
i.e. its metabolism, is determined by the physical and chemical
form of the radioactive material and its associated iji vivo
solubility. The fate of the radionuclides in the body is
governed by the following factors: 1. Permeability, 2. Ligand
Exchange, 3. Transport, A. Assimilation, 5. Storage, 6. Excretion
2 . 1 . 1 . Ingest ion
When a rad ionucl ide i s inges ted , i t passes through the
g a s t r o i n t e s t i n a l t r a c t mixed with the contents of the t r a c t .
During t h i s t r a n s i t , a f rac t ion of the rad ionucl ide may be
absorbed, and the remainder i s excreted in the f eces . The
f rac t ion absorbed can be very high, as .>.n the case of soluble
rad ionuc l ides such as t r i t i u m , iodine or cesium, or very low, as
in the case of r e l a t i v e l y inso lub le f orris of rad ionucl ides such
as plutonium or uranium . The absorbed f rac t ion i s c i r cu l a t ed via
the bloodstream and depending on the element, i t wi l l be
deposi ted in specif.'.c organs where metabolic fac to rs control i t s
depos i t ion and i t s ' u r the r excret ion via the ur ine and feces .
2 . 1 . 2 . Inha la t ion
Various f r a c t i o n s of inhaled m a t e r i a l , depending on p a r t i c l e
INGESTION INHALATIONWOUNDS,
SKIN ABSORPTION
G.I.
TRACT
EXHALATION
LMECHANICAL
CLEARANCE
PROCESSES
VRESPIRATORY
TRACT
PULMONARY
LYMPH
NODES
DISSOLUTIONAND ABSORPTION
PROCESSES
VSITE OFENTRY
Fig.l Schema'Jc representation of routes of entry, metabolic pathways and
possible bioansay samples for internally deposited radionuclides (NCRP 87).
s i z e , a re deposi ted in d i f f e ren t regions of the respiratory-
t r a c t , (Nasopharyngeal, Tracheobronchial and Pulmonary regions)
and the f r ac t ion not deposi ted i s exhaled. The regional
depos i t ion of the inhaled mate r ia l i s inf luenced by the
c h a r a c t e r i s t i c s of the inhaled mate r ia l (ch ie f ly s i ze ) and by the
anatomic and phys io log ic s t a t u s of the s u b j e c t . Once depos i t ed ,
the e l imina t ion and systemic absorpt ion of the mate r ia l a r e
governed by the s i t e s of depos i t ion and by the phys ica l and
chemical p r o p e r t i e s of the inhaled p a r t i c l e s . For i n s t a n c e ,
p a r t i c l e s depos i ted i n i t i a l l y on the c i l i a t e d ep i the l ium of the
r e s p i r a t o r y t r a c t a re c leared rap id ly by mucoci l iary a c t i v i t y
followed by swallowing and passage through the g a s t r o i n t e s t i n a l
t r a c t . Retent ion of mate r ia l deposi ted i n i t i a l l y beyond the
leve l of the c i l i a t e d ep i the l ium ( i . e . below the terminal
b ronch io les ) i s s t rongly influenced by the s o l u b i l i t y of the
mate r i a l in the body f l u i d s . If the inhaled mate r ia l i s so luble
in body f l u i d s , s i g n i f i c a n t absorp t ion to the bloodstream can
occur through the t i s s u e of the upper r e s p i r a t o r y t r a c t or
g a s t r o i n t e s t i n a l t r a c t during t h i s c learance p r o c e s s . Soluble
13 7 90
m a t e r i a l s ( CsCl or SrCl ) a r e qu ick ly absorbed i n t o the
blood stream. R e l a t i v e l y i n so lub l e forms a re r e t a ined in the
pulmonary region for longer times and a re subject to removal by
both mechanical and d i s s o l u t i o n - a b s o r p t i o n p r o c e s s e s . Fac to r s
that can inf luence the in -v ivo s o l u b i l i t y of an i n f e r n a l l y
deposi ted r ad ionuc l ide inc lude i t s elemental chemistry, chemical
form, surface a r e a , and spec i f i c a c t i v i t y . Radionucl ides a r e
c l a s s i f i e d i n to th ree ca t ego r i e s based on t h e i r b io log i ca l
c learance half t imes in the pulmonary region; 1) 'D1 C l a s s :
clearance half time ranges up to 10 days, 2) 'W Class: Clearance
half time ranges from 10 to 100 days, 3) 'Y' Class: Clearance
half time is greater than 100 days.
2.1.3. Absorpt i on
In the case of a puncture v/ound, solubility influences the
rate at which the deposited material will leave the wound site
via the lymph and enter the circulation for distribution to
vari ous organs .
2.2. Object ives of Bi oa ssay Programme
2.2.1. Evaluat i on of Int ernal Deposi t i on
The primary use of bioassay methods is to determine whether
an individual has been exposed to a radioactive material in a
manner that resulted in an internal deposition and, if so, to
quantify the magnitude of that deposition and its dosimetric
consequences. It plays an important role in the medical
management of potentially over-exposed individuals. Routine
scheduled measurements, performed periodically after an
individual is on the job, provide important input for evaluations
of the extent to which the individual is adequately protected, is
observing safe working practices, and is avoiding the
accumulation of internally deposited radionuclides. Bioassay
results may be obtained when an individual takes up new job
assignment and when an individual terminates a particular job
assignment to document the estimated body or organ burden at that
t ime .
2.2.2. Evaluat ion of Cent rol Procedures
Bioassay provides a useful tool for evaluating the general
conditions of exposure throughout an operating facility. It gives
important base line data and provides useful background
information on exposures that might have occurred in past
occupational assignments. It can indicate trends towards greater
or lesser accumulations of radioactivity within the working
population. Bioassay results can provide information on
possible exposures associated with unusual procedures for which
experience is not available, and on exposures that have been
occurring but were not suspected. These results can also indicate
the extent to which engineered confinement-measures and the air
sampling programme have been effective in the control of the
exposures .
2.2.3. Improved Metaboli c Data
Many guidelines and standards are based, in large part, on
results obtained from laboratory animals exposed to radionuclides
by different routes of administration. The models used in these
documents are based on appropriate extrapolations to human
exposures. Thus, the bioassay data from human exposures are
invaluable in the development of standards and the validation of
extrapolations of •animal data.
2.3. Bioassay Techniques
Bioassay is the determination of the kind, quantity,
location, and/or retention of radionuclides in the body. Bioassay
methods are used to estimate the body-burden of radionuclides and
their distribution among different organs due to internal
radiation exposure. Because the direct anal/sis of tissue samples
is seldom possible in living persons, other methods must be used.
The two main types of bioassay measurements are:
*) In~vivo measurements (Whole Body Counting)
2) In-vit ro measurements (Analysis of Urine, feces, blood,
breath et c . )
2 .3 .1 . In-vivo Measurement s
In-vivo measurements are those in which the emission of
photons from internally deposited radionuclides is detected
external to the body. It is commonly used for routine
surveillance of workers to detect possible unknown exposures and
to measure the quantities in the body and, possibly, organs when
such an exposure is detected.
Many different types of systems (generally described as
whole-body counters) have been devised to accomplish these in-
vivo measurements. In a laboratory setting, systems in use range
from single, unshielded detectors to heavily shielded (with lead
or steel) multi-detectors . Factors that can influence the
complexity of the system include the accuracy and precision
required, the distribution and behaviour of the material in the
body, and the nature of the radiations emitted. The detector may
be a solid, inorganic scint i l la tor (e.g. Nal(Tl)) or an organic
scint i l la tor in either a liquid or solid form.
Multiple, fixed-position Nal detectors provide more
sensitivity and geometry independence than a single crystal while
s t i l l maintainina the resolution inherent in Nal detectors.
Obviously, the initial cost and the maintenance needed for the
electronics increases considerably with the number of detectors
used. A hyperpure germanium detector provides better energy
resolution than the other systems. Multi-detect or arrays of
hyperpure germanium detectors have been successfully used to
238 23Q 241quantify lung burdens of actinides such as Pu, Pu, Am,
U and ^°U. Thyroidal uptake of 1 0 1I or I is readily
monitored by an external Nal(Tl) probe.
2.3.2. In-vit ro Measurement s
2.3.2.1. Urine Analysis
The urine specimen has been referred to as a liquid tissue
biopsy of the urinary tract, painlessly obtained. Nutritional
state, the state of metabolic processes, and the ability of the
kidney to selectively handle the material presented to it are the
three principal factors affecting the composition of the urine.
About 1200 cm /min of blood passes through the kidney,
exposing the plasma to the semipermeable membrane of each
functioning glomerulus. The ultrafiltrate that collects in
Bowman's capsule contains all the substances of plasma capable of
passing through the membrane. Modification of this filtrate
occurs in the tubules and collecting duct of the nephron to
produce the urine. The average daily excretion of urine in normal
adult is 1400 cm (normal range is 600 - 2000 cm ).
A large proportion of urine solute is made up of urea and
sodium chloride. Other than nitrogenous material ( e.g., ammonia,
creatinine, etc.) and salts (e.g., sulphates and phosphates),
urine contains small amounts of sugar and intermediary
metabolites such as oxalic acid, citric acid and pyruvate. Free
fatty acids and trace amounts of cholesterol are also found, as
are trace amounts of metals. Hormones such as ketosteroids,
estrogens, aldosterone, and pituitary gonadotrophins and biogenic
amines (catecholamines and serotonin metabolites) are normally
found in the urine and reflect metabolic and endocrine status.
Vitamins such as ascorbic acid are excreted in amounts that
depend on the sufficiency of dietary intake. Trace amounts of
porphyrins and delta-aminolevulinic acid are present. Normal
urine contains traces of red blood cells and leukocytes, renal
tubular epithelial cells, transitional epithelial cells, and
squamous epithelial cells, which represent normal sloughing off
of aged cells^
Urine analysis for radioactive material provides a useful
assessment of the existing systemic burden. Urine analysis can be
par t i ci'larly useful when equipment and facilities for external
detection of radionuclides are not available on a routine basis.
3 14Also, because some radionuclides, such as H or C, emit low
energetic beta particles without accompanying gamma photons,
external detection is not possible. Periodic routine analysis of
urine indicates an internal exposure that may not have been noted
through an air sampling programme. Urine analyses can be used to
assess the performance of the radiation protection control
practices. Also, in the case of an individual with a known body-
burden of a radionuclide, sequential analyses of urinary
excretion may provide the basis I r estimating the fraction of
the annucl limits on intake that was deposited in a transferable
10
form. When a radionuclide reaches the circulation in ionic or
complexed form, fractions are deposited in different organs and
filtered by the kidneys depending on the chemistry of the
radionuclide. This fraction is subject to dynamic equilibrium
based on the chemistry of the radionuclide and the cellular
dynamics and biochemistry of the target organs. The radionuclide
subsequently released from these organs by cellular turnover or
other kinetic processes, re-enters the bloodstream where it again
undergoes fractionation (including possible translocation to
another body organ) with continuing excretion in the urine and
feces. Thus one can derive an indirect assessment of the amount
remaining in the body from measurements of the amounts of a
7 8 9radionuclide excreted from the body ' ' .
Since the method is an indirect assessment of body-burden,
one must adopt a model that describes the expected behaviour of
the material in the body and the temporal excretion
relationships. One of the limitations of urine analysis is the
degree to which the behaviour of the material in the subject
being tested matches that incorporated in the model being used.
Discrepancies of this sort can be caused by differences in the
subjects, the forms of the material deposited, and the mode of
intake.
Long-term retention of radionuclides with nearly uniform
' 137distribution throughout the body, e.g. ""H and Cs can be
adequately described by a single exponential function. In such
cases, the urinary excretion should represent a constant fraction
of the total existing body burden regardless of the elapsed time
11
after exposure. For other radionuclides, the urinary excretion
patterns are best represented by multiple exponential functions,
power functions or their combinations, and it is necessary to
know the time elapsed between exposure and sample collection to
relate urinary excretion to body burden. The time after a single
exposure may be known. When the subject has accumulated multiple
depositions, however, the effective time after exposure is
difficult to determine in relation to the model used.
Interpretation of the data is also complicated when the
individual i s , or has been, undergoing chelation therapy for
removal of the deposited material because the levels of
radionuciide excretion in the urine will be elevated over those
observed without chelation.
2.3.2.2. Sampling of Urine
Care must be exercised in the collection of bioassay samples
to prevent contamination. Clean containers must be used for
collection and storage; single-use containers can meet this
requirement most readily. All biological samples are also subject
to deterioration by bacteriological action that may interfere
with subsequent analysis. Prompt analysis following collection is
the preferred method of avoiding these complications. When
samples must be kept longer than a day, they should be
refrigerated, acidified to minimize precipitation, or have a
preservative added ;o prevent bacterial growth. For some
analytical techniques, it may be appropriate to add a carrier to
minimize losses to the container walls or to obtain high recovery
of the T.adi oact iv= material .
12
In many dosimetric evaluations, the quantity of radioactive
material excreted per 24 hours is required and is obtained by
collecting a 24-hour urine sample. For a routine bioassay
programme, collection of 24-hour samples may be diff icult because
collection is required both at home and during working hours when
the possibi l i ty of sample contamination is high. Samples
collected just before ret i r ing at night and al l samples until and
including the f i rs t voiding after rising in the morning on two
successive days will approximate the volume of a 24-hour sample,
and such samples are suitable for many s i tuat ions . Such samples,
called incremental samples, represent the integral excretion over
the collection period, and account must be taken of this if the
excretion rate i s changing rapidly during this period. For some
materials, such as natural uranium, 24-hour samples are not
essential for control purposes. Analysis of a single voiding will
give adequate evidence cf exposure if any. In this case,
consideration must be given to the time of sample collection.
Except when true 24-hour samples are collected, some
correction of the concentration measurement may be required to
account for abnormal conditions of high or low fluid intake or
excessive loss of water by perspirat ion. This correction is
frequently made by relating the specific gravity (sp.gr.) of the
sample to the average sp.gr. of urine which is 1.024 g/cm . The
correctinr to be applied is determined from the relation
Corrected concentration
= (n.easuted concent rat i on )(1 . 024 -1 )/(measured sp.gr. - 1)
13
An alternative correction may be made based on the fact that
creatinine is excreted at an average rate of 1.7 g/d for men and
1.0 g/d for women . The ratio of the expected creatinine content
to the measured creatinine content of the sample provides a
correction to convert the amount of radioactive material in the
sample to the equivalent of a true 24-hour collection. Sample
volume for a 24-hour collection or the volume collected over a
known time interval may be indicative of a need for correction.
If urine samples are to be taken to evaluate exposure or dose
following an accidental exposure, a urine sample should be voided
immediately following the exposure and cleanup, if possible. This
action avoids dilution of the subsequent sample by urine already
present in the bladder at the time of the incident. This
immediately voided sample may also be analysed to provide
baseline data .
2.3.2.3. Feces Analysi s
Feces analysis is another means of obtaining an indirect
assessment of the body-burden of an internally deposited
radionuclide. It can be useful in detecting and quantifying an
inhalation exposure to a relatively insoluble form of
radionuclide, because clearance via feces is the predominant
12 13excretion mode in such a situation ' . Collection and analysis
of feces sanples, ascertaining and quantifying radioactive
material in them and interpreting the results are more difficult
than in the case of urine. The daily rate of fecal mass excreted
is considerably more variable than the daily rate of urinary
14 15voluine ' . While the specific gravity or creatinine content of
14
the urine can be used to adjust or normalize the result of a
urinalysis, no similar index has been identified for feces.
2.3.2.A. Blood Analysis
Another possible means of estimating the burden in an
individual is to measure the radionuclide content of a blood
sample which would generally be comparable to that obtained from
urine analysis. Blood samples show less fluctuation in
radionuclide content than do urine samples, but the sensitivity
of the analysis is limited, due to the amount of blood that can
be withdrawn from an individual, particularly in the event of an
accident with severe injury. Unfortunately, many elements are
rapidly taken up by organs or bound to tissues and are only
slowly released back to blood. Thus, blood bioassay, even a few
hours after exposure could result in misleadingly low
interpretations of blood activity concentrations. Becuase of
these factors, as well as the ease of sampling urine, blood
sampling is rarely used to monitor the possible uptake of
radi onuclidfjs in individuals working with radioactive materials
under normal conditions. However, in a serious exposure the level
of radioactive material in the blood could be high enough to
allow accurate analysis of a small sample of blood.
2.3.2.5. rSreath Analysi s
Breath samples have been analysed to estimate the internal
deposit! on of radiun. and thorium nuclides. Breath samples can
also bo applied to ;;ome other radioactive materials t! at produce
a gas or vapour in the body. R:-idon-222, the decay product of
2 ° 6
Ha, can be collected with air handling systems that incjude
flasks, sampling bag, spi rornet ers, or charcoal traps (the latter
two permitting measurement of exhalation rate as well as
concentration) and measured with ionization chambers or
scintillation devices. Radon-220, eventual decay product of
2 2 8Th or Th, can be sampled by electrostatically collecting
its ionized daughters and counting with solid state detectors.
2.4. Frequency of Monit oring
If the concentration of radionuclides is normally low (the
time weighted average does not exceed 10% of Derived Air
Concentration) and if transient elevations in this level are
infrequent and not great (not more than three times of the
chronic level) annual bioassays may be adequate. If the average
concentration of radioactive material in air normally exceeds
10% of the Derived Air Concentration and/or transient elevations
tend to be more than three times of the chronic level, it is
unlikely that annual bioassays will adequately monitor the
accumulated radioactive material in the body. Under such
conditions, bioassay measurements should be conducted often
enough to assure that significant depositions do not go
undet ect ed .
For a radionuclide such as inorganic tritium, however, which
has a short effective half life and therefore does not accumulate
in the body, the objective of monitoring does not apply. Bioassay
for such substances, if it is considered necessary for the
particular circumstances, is usually done more frequently than
annually to confirm air sampling results.
16
3. PRECONCENTRATION METHODS
In practice, the chemical analysis demands various
preconcentration techniques depending on the matrix. If the
matrix is simple, i.e., it contains one or two trace elements
then the preconcentration can be effected by removal of the bulk
of the matrix and thereby separate the trace elements. However,
if the matrix contains several elements then it is ideal to
separate trace elements from the matrix. In general removal of
matrix demands large amounts of reagents and time and incurs
losses of the trace elements being concentrated . Hence removal
of matrix is not a preferred method for bioassay of urine
samples.
Selecting a preconcentration method is mainly governed by
(I) the nature of the trace elements to be determined, (II) the
combination of the selected method and subsequent method of
determination of trace elements in a concentrate, (III) the
simplicity, the availability and the duration of the method, (IV)
the availability of the equipment and (V) mutual effects of the
matrix and trace elements in the process of sample treatment.
3.1. Solvent Ext racti on
Solvent extraction is a method of isolation, separation and
concentrations of substances; it is based on the distribution of
dissolved substances between two immiscible liquid phases. Most
commonly water forms one phase and the organic solvent the other.
This method can be applied both for the removal of matrix and for
the selective, group, or subsequent separation of trace elements
17
effectively. The important advantage of extraction methods is
that they are universal with respect to the type of elements to
be isolated and to their concentration. Simplicity and rapidity
are other advantages of these methods. Usually solvent
extraction can be combined with different methods of subsequent
det erminat i on.
3.1.1. Ext ract i on u sing chelat es
For extracting trace elements chelates are often used. These
are compounds of metals with organic polydentate reagents. The
general formula of most common chelates is MA , where A stands
n
for the anion of the reagent which is a weak acid and n
represents the metal ion charge. Chelates can be coordinatively
saturated and unsaturated. In the l a t t e r , the central atom of
metal is capable of adding neutral ligands, such as water, into
the inner coordination sphere. Thus, the nature of the solvent
has a marked effect on the extraction of chelates. Coordinatively
saturated complexes are extracted with different solvents.
Group extraction of trace elements pursues the objective of
isolat ing a maximum number of elements in a single step using a
minimum number and amount of chelate-forming reagents which can
be easily purif ied. The composition of the aqueous phase
significantly affects the extraction efficiency of chelates.
3.2. Ext ract i on Chromat ography
Extraction chrorr.at ography is an effective method of
concentration and separation. It can be regarded as a peculiar
variant of continuous extraction- the compound to be extracted is
18
distributed between two liquid phases, one of which is fixed on.
a solid inert carrier placed in a column, while the other travels
along the column. The chemical nature of the process happens to
be extraction, while the technique of carrying out the process
is chromatography. In a number of cases, column extraction
chr^matography has advantages over the usual solvent extraction.
Elements with almost similar properties can be separated, e.g.
lanthanides, act inides, zirconium-hafnium, niobium-tantalum, e tc .
Other advantages include the high degree of absolute
concentration and the possibi l i ty of carrying out experiments in
s t e r i l e and isolated conditions and , hence of lowering the value
and the fluctuations of the blank experiment correction compared
to conventional extraction. Extraction chromatography can be
easily controlled to achieve group or selective concentration.
Good results can be obtained by correct selection of the
extraction system and the composition of the aqueous phase,
part icular ly by adding masking-substances, oxidisers, reducers,
and also by controlling of the conditions of separations. The
la t t e r depends on the parameters of the chromatographic column,
e.g. , height of the theoretical plate (HTP) and the number of
such p la tes . HTP depends on the column contents, the nature and
granulation of the carr ier , the elution ra te , temperature, the
type of extractant and i t s amount, i t s degree of dilution with
17neutral solvents and the composition of the aqueous phase
3 . 3 . SORPTION METHOD 5
Sorpcion techniques prove to be most e f f ec t ive in those
cases when the subsequent method of determinat ion may suffer from
19
mutual interfering effects of trace components. The mechanisms
involved in sorption phenomena are many, viz., (I) adsorption
(sorption of substances on the surface of a solid or liquid
body), (II) absorption (sorption of gases, vapours or substances
dissolved in the volume of a solid or liquid phase), (III)
chemisorption (sorption of substances by solid or liquid sorbents
with the formation of chemical compounds) and (IV) capillary
condensation (formation of a liquid phase in the pores and
capillaries of solid sorbent during sorption of vapours of the
substance). In practice it is difficult to encounter separately
any of the above mentioned types of sorption: they are generally
used in combination with each other. For e.g., adsorption usually
precedes chemisorption. Adsorption and chemisorption methods are
widely used for concentration of trace elements. Among the latter
extensive use is made of ion-exchange and sorption which is
accompanied by complex-formation, say, on chelate forming-
sorb ent s .
Sorption generally ensures good separation and high values
of concentration coefficients. For concentration of trace
elements use is made of different sorbents which, besides having
good sorption power and selectivity, should have the ability to
be easily regenerated, and be chemically and mechanically stable.
The following sorbents are in general use: normal and modified
cellulose, ion-exchange and chelate synthetic sorbents and
different inorganic sorbents. For quantitative estimation of
sorption, use is made of the degree of separation and the
distribution coefficient.
20
3.3.1. 5yntheti c Ion Exchangers
Synthetic ion exchangers are usually made of copolymers of
styrol and divinylbenzene having divinylbenzene cross-links. The
degree of cross-links determines many important properties of the
the sorbent , in particular, swelling ability and sorption rate.
Use is mostly made of strongly cross-linked sorbents (up to 10 or
more percent divinylbenzene) which comprise fine grains (100-400
mesh). Ion exchangers with acidic groups (S0«H ) can exchange
cations, and are called cation exchangers; sorbents with basic
groups [N(CH3)30H ] can exchange anions, and are known as anion
exchangers. The essence of an ion-exchange process is to replace
the sorbent counterions (for instance, H in the case of SO H )
with the ions of the elements to be concentrated, which are
present in the analysed solution. In an ion-exchange method, use
is often made of complexes of elements present in the analysed
solution or especially obtained prior to preconcentration.
Complex formation enables the difference in sorption behaviour of
separated elements to be increased, sometimes very significantly;
in particular, one of the elements to be separated is transferred
into an anion complex and the other is kept as cation. For
example, anionic complex of plutonium hexanitrate is adsorbed on
the anion exchange resin while other actinides are eluted, to
46achieve the separat ion of Pu in urine
3.4. Co-precipi t a t i on £j t race element s
Co-prec ip i ta t ion i s the t rans fe r of a substance in to a
p r e c i p i t a t e of some compound if the substance does not form i t s
own solid phase under given condi t ions . Co-prec ip i ta t ion i s the
21
best suitable and much more extensively used method of
preconcentration for the separation of trace elements. Greater
selectivity in co-precipitation can be attained by masking,
changing the oxidation state of elements, and by applying other
techniques. Co-precipitation is mainly due to adsorption of the
trace component on the surface of the collector and/or the
formation of isomorphic mixed crystals. The formation of mixed
chemical compounds, occlusion and mechanical inclusion of small
amounts of other phases also favours co-precipitation. Sometimes
all these factors act simultaneously to some extent. Adsorption
increases with the growing surface area of the crystal and with
the decrease in the solubility of the compounds of the trace
element which it (the element) forms with oppositely charged ions
of the crystal .
The precipitate formation process is quite complicated and
often it does not proceed instantaneously. Its progress depends
on various factors, such as composition of the aqueous phase, pH,
temperature, nature of the counter-ions forming the precipitate,
sequence in v/hich solutions are mixed, and the properties of the
collectors. Co-precipitation on inorganic and organic collectors
ensures high efficiency of absolute concentration.
3.4.1. Collect ors (Carriers )
The collectors (carriers) of trace elements must meet
specific requirements. They must entrap the necessary element
without picking up the matrix and interfering trace elements.
The main requirement is that the collector should easily separate
22
from the matrix solution by just f i l ter ing, centrifugation and
washing the precipitate. It is desirable that the collector
should be available readily and measured easily. For e.g.,
Fe(III) and Al(III) are the most widely used collectors for
concentrating radioactive trace elements in urine.
In certain cases there is no need to specially introduce an
element carrier, for it is already present in the solution to be
analysed in micro- or macroamounts. In such cases, the matrix is
part ial ly precipitated by regulating the amount of the added
precipitant. This technique i s , however, applicable only when
the solubility product of the precipitated compound of the matrix
element is more than the solubility product of the corresponding
compounds of trace elements. The most common technique is to
introduce the element-carrier and a suitable co-precipitant into
the analysed solution. The co-precipitants can be classified as
inorganic or organic co-precipitants.
3.4.2. Inorgani c co-precipitants
For co-precipitation of trace elements with inorganic
collectors, use is often made of amorphous precipitates with
large active surfaces (hydroxides, sulphides, phosphates and
others). For example, most of the actinides in urine are being
concentrated by co-precipitation with calcium as phosphate
(Table 1). Plutonium is co-precipitated in the form of ferric
hydroxide and Tc-99 in the form of copper sulphide ' '
The precipitates formed in the sorption processes have a
large surface and porous structure, and therefore the whole
23
volume of the finely dispersed prec ip i ta te is easily accessible
to the ions present in the solution. These processes can be both
physical and chemical, Examples (I) ion exchange observed in the
co-precipi tat ion of sulphides and hydroxides, (II) exchange of
cesium ions with ammonium ions on Ammonium Molybdo Phosphate in
24 25the estimation of cesium in urine '
3 .4 .3 . Organic precipi tant s
The effectiveness of organic co-precipi tants i s so great
that a trace component can be isolated even when i t i s present in
solutions in the ra t io of 1:10. Organic co-precipi tants often
separate out in the p rec ip i t a t e on mixing the solution to be
analysed with solutions of reagents. Ion associates containing
methyl viole t cation and complex thiocyanate anion of uranium co-
prec ip i t a t e to form sparingly soluble p rec ip i t a te in the
77determination of natural uranium in urine . In th i s case the
element enters into the composition of the complex anion. Other
examples of organic co-precipi tants include potassium
rhodizonate for strontium estimation , tetraphenyl arsonium
chloride for Tc-99 determination and Sulkowich reagent for Pu
1 ft *} C
estimation in urine '
^ • 5 • E1ec11ochemi ca1 method s
Electrochemical methods of preconcentration (electrodeposi-
tion, cementation, electrodialysis and others) are used for
analysis of various natural and industrial materials. These
methods ensure high efficiency of preconcentrat ion. Techniques
involving electrochemical concentration (ECC) make it possible to
vary the elemental composition of the concentrate by changing the
24
conditions under which electrochemical processes proceed. They
do not require large amounts of chemical reagents (here
electr ic i ty is the main reagent) and are accessible practically
for any laboratory.
3.5.1. Electrodeposition
Electrodeposition is the most commonly used method of
electrochemical concentration. The behaviour of an element during
electrolysis is determined by i t s electrochemical potential , the
general composition of the electrolyte, current density, material
and design of electrode, temperature, mixing rate and the
constructional features of the electrochemical ce l l . In the
electrolysis of multicomponent solutions, the voltage applied at
the cell is more negative (for cathode processes) or more
positive (for anode processes) than the values of the
equilibrium potential of the corresponding oxidation-reduction
systems calculated by the Nernst equation. The cathode processes
are of great significance for preconcentration, which can be used
for both separation of macrocomponents and concentration of trace
elements. Since trace elements are electrodeposited from very
dilute solutions, the rate at which the components are
transported to the surface of the electrode and the electrode
potential become important factors. Electrodeposition i s used for
concentration of trace elements prior to their determination by
other instrumental methods. In the bioassay, this method is used
for deposition of Pu on the stainless steel planchet and the same
is counted by alpha spectrometry.
i*. INSTRUMENTATION
Instruments commonly used for bioassay of radionuclides
(Table 2) are alpha counters {like alpha scintillation counters,
alpha spectrometer, liquid scintillation counter), low beta
counter, gamma ray spectrometers using Nal(Tl) or hyperpure
Germanium detectors etc. Nuclear track counting technique is also
used for low level measurement of alpha emitters. In addition to
nuclear instruments, spectrophotometer and fluorimeter are also
used for some of the radioelements having very low specific
activity such as thorium and uranium.
Sensitive detection methods are essential for effective
radiation exposure control programme. Annual limit on intake for
alpha emitting radionuclides is very low. Fission Track counting
met nods can be used for plutonium estimation in urine but it
takes ,—'30 days time to detect the reference levels specified by
ICRP . Alternatively, alpha spectrometer, gives good resolution
(20 keV at 5.5 NieV) and very low background under the vacuum
condition of 100 mPa - 100 uPa required for the instrument
operation. This instrument is very useful for simultaneous
determination of nuclides emitting alphas of various energies.
Pu, Th and U are routinely being monitored in urine using this
instrument. In order to meet the reference levels specified by
ICRF1, it is necessary to improve the sensitivity of detection for
the above nuclides in urine.
As chemical separation yields are already extremely high,
the detection limit can only be improved significantly by
optimising the operation of the counting device (background.
26
efficiency) and by extending counting time. The background
results from both natural background radiation and nioses in the
detection systems. This can be brought down by using appropriate
shielding and special electronic circuits. Counting time cannot
be markedly increased due to practical limitations.
Improving the detection limit without chemical processing of
the sample is the most advantageous method. In a modern bioassay
programme, computer assisted Nal(Tl) and hyperpure Germanium
detectors are routinely being used for detecting the gamma
emitting radionuclides in urine. Background of these detectors
depends on the energy of the radionuclide to be counted and
increases as the energy decreases. Efficiency falls exponentially
with the energy of the nuclide. It also depends on the distance
from the source; efficiency increases as distance from the source
decreases. In general HPGe detector efficiency is ten times less
than the efficiency of Nal(Tl) detectors but gives good
resolution and much lower background. Detection limits for the
nuclides depends on the background reading in the integrated
channels. J".n general these background readings are very low for
HPGe detectors. It is therefore, preferable to use HPGe
detectors for routino monitoring of gamma nuclides in urine.
5 . ICRP RECOMMENDAT .IONS FOR INTERNAL DEPOSITION OF RAD IONUCL IDES
The International Commission on Radiological Protection
(ICRP) poriodical1y brings out reports containing recommendations
to ensi re the exposures of radiation workers and the public are
kept wisll within the safe limits. ICRP-54 contains details of
27
individual monitoring for intakes of radionuclides by workers
including design and interpretation.
It is mentioned that a great improvement in the detection
limit is needed because the derived recording levels for routine
monitoring mentioned in ICRP-54 are lower than the detection
limits reported in literature (see Table 3). The aim of the
Bioassay programme is to assess the amount of radionuclide
present in the body, estimate the resulting exposure and compare
it with limits prescribed by ICRP. These limits are given in
terms of Annual Limit on Intake, Derived investigation and
Derived recording levels.
5.1. Annual Limi t on Intake (ALI)
ALI is the greatest value of intake 'I' which satisfies both
the following inequalities
I, £. WT (H50 T per unit intake) <: 0.05 Sv and
I, (H per unit intake) •£ 0.5 Sv
which represent respectively the limits for st ochasv. i r. and non-
st ochast i c ef feet s .
Here, I = Annual intake of the fjiven radi onucl iie either by
inhalation or ingestion ( it is expressed in Bq)
V.' - Weighing factor .md
K T per unit intake- = commi 11 r. H dose equivalent in Tissue
(T) from the intake of ui.it activity of the giver, radionuclide by
the specified route in :50 /ears following the intake (expressed
in SvDq )
28
5.2. Derived Invest igat i en and Derived Recording Levels
The quantities normally measured in individual monitoring
programmes for intakes of radionuclides are body or organ
content or activity excreted per unit time. It is convenient to
compare the measured results directly with Derived reference
levels, viz.. Derived investigation level (DIL) and Derived
recording level (DRL). Calculations of Derived reference levels
require assumptions about the time and pattern of intake and the
use of models of intake, deposition, metabolism and retention.
Derived investigation and recording levels are calculated
separately and are given in ICi?P-54.
6. CONCLUSIONS
Various methods c i ted in l i t e r a t u r e for car ry ing out the
a n a l y s i s of r a d i c n u c l i d e s in u r ine have been reviewed. Minimum
de tec t i on l i m i t s repor ted in the l i t e r a t u r e a re compared with
the Derived recording l e v e l s spec i f ied by ICRP for rou t ine
monitoring purpose . '-is per the Table 3, Cs-137 and Sr-90 can be
de tec ted much below the reference l e v e l s ind ica ted by ICRP-54 for
rou t ine monitoring purpose . The method for assay of plutonium in
u r i n e which g ives d e t e c t i o n l i m i t s lower than the recording level
speci f ied by ICRP i s by F i ss ion Track a n a l y s i s which takes < 30
days . This time dura t ion i s r a the r laxgn for rou t ine monitoring
schemes. In the case of uranium, to achieve s imi la r ob jec t ive one
has to use Thermal I c n i s a t i o n MJSS Spectrometry which i s an
expensive equipment. Ii the case of Ru-106 (Class Y), the
de t ec t i on l imi t (20 Bq/dro' ) for ur ine assay quoted in ICRP 54 i s
not adequate for rou t ine monitor ing. Radionucl ides such as
29
n a t u r a l t h o r i u m ( I ' h - 2 3 2 ) a n d U r a n i u m - 2 3 5 a r e n o t d e t e c t e d a t t h e
r e f e r e n c e l e v e l s s p e c i f i e d b y I C R P . i t i s n o t e d t h a t t h e r e
e x i s t s a g o o d s c o p e f o r d e v e l o p m e n t o f a n a l y t i c a l m e t h o d s f o r t h e
d e t e r m i n a t i o n o f R u - 1 0 6 , n a t u r a l t h o r i u m , n a t u r a l u r a n i u m a n d P u -
2 3 9 i n u r i n e w h i c h w o u l d o f f e r h i g h s e n s i t i v i t y w i t h m i n i m u m
a n a l y s i s t i m e a n d a t l o w c o s t .
7 . A C K N O W L E D G E M E N T S
A u t h o r s w i s h t o e x p r e s s t h e i r s i n c e r e t h a n k s t o S r i L . V .
K r i s h n a n , H e a d , S a f e t y R e s e a r c h & H e a l t h P h y s i c s P r o g r a m m e , f o r
t h e e n c o u r a g e m e n t a n d s u p p o r t g i v e n t h r o u g h o u t t h e p r e p a r a l i ^ n r>f
t h i s r e v i e w . A u t h o r s a r e g r a t e f u l t o D r . P . R o d r i g u e z , H e a d ,
M e t a l l u r g y a n d M a t e r i a l s P r o g r a m m e a n d D r . O . M . S r e e d h c . r a n ,
H e a d , T h e r m o d y n a m i c s S e c t i o n , M e t a l l u r g y D i v i s i o n , f o r v a l u a b l e
d i s c u s s i o n s a n d s u g g e s t i o n s .
30
8. REFERENCES
1. "Individual Monitoring for Intakes of Radionuclides by workers:Design and Interpretation," ICRP 54 (1988).
2. Venketesh Iyengar, G."Biomedical Environmental Compositional and Methodological aspectsof Trace Elements" in "Elemental Analysis of Biological Systems",Vol. 1: CRC Press Inc., Doca Raton (1989)
3. Friberg, L."The Rationale of Biological Monitoring of Chemicals with specialReference to Metals"Am. Ind. Hyg. Assoc. J. 46, 633 (1985).
4. "Use of Dioassay Procedures for Assessment of Internal Radi onu elideDeposi t i on , "NCRP Wo.87, Hethesda, Maryland (1987).
5. "Limits for Intakes of Radionuclides by Workers",ICRF 30, Part 1, Ann. of the ICRP 2, No. 3/4 (]979).
6. ''Assessnebt if Radioactive Contamination in Man 1984"IAEA Publication No.STI/PUB/674, IAEA, Vienna (1985).
7. Jackson. 5. and Dolphin, G.W.' T h e e s t i m a t i o n of I n t e r n a l R a d i a t i o n Dose from M e t a b o l i c andU r i n a r v e x c r e t i o n d a t a f o r a number of i m p o r t a n t R a d i o n u c l i d e s , "H e a l t h P h y s . , 1 2 , 481 ( 1 3 6 6 ) .
8 . " R e p o r t of C o m m i t t e e IV on E v a l u a t i o n of R a d i a t i o n D o s e s t o BodyT i s s u e s f rom I n t e r n a l C o n t a m i n a t i o n Due t o O c c u p a t i o n a l E x p o s u r e , "ICRP 1 0 , Pe rgamon P r e s s , New York ( 1 9 6 8 ) .
• . " R e p o r t of C o m m i t t e e IV on t h e A s s e s s m e n t of I n t e r n a l C o n t a m i n a t i o nR e s u l t i n g frorr. R e c u r r e n t o r P r o l o n g e d U p t a k e s , "ICF!P P u b l i c a t i o n 10A, Pe rgamon P r e s s , New York ( 1 9 7 1 ) .
i C . " C r i t e r i a f o r a Recommended S t a n a d a r d - O c c u p a t i o n a l E x p o s u r e t oHen z e n e , "i i ! r V ; P u b l i c a t i o n ( N I O S H ) 7 4 , V . S . G o v t . P r i n t i n g O f f i c e ,V . 'a s h i r i g t o n , D . C . ( 1 9 7 4 ) .
1 1 . J a c k s o n , i" .T r e a t i n i n o i n u r i n e a s a i n d e x o f u r i n a r y e x c r e t i o n r a t e "H e a l t h P h v s . , i 2 , 8 4 3 U 3 6 >: , .
I . . . L a k i n s , J . D . anri M o r g a n , / . .
'"i h c r o l e c £ f e c a l a n a l y s . s ; ;i a b i c a s s a y p r o g r a m m e , "
A s s e s s m e n t ' i f i i a d i o a c t . v i e / i n Mc ,n , " _1 , I A E A P u b l i c a t i o n
'Ac . S T T / P U B / 8 4 , I / v ^ A , V i e n n a , p . 2 3 1 ( 1 9 c 4 ) .
3 1
1 3 . G u i I m e t t c , R.A ."A l o w - e n e r g y p h o t o n d e t e c t o r f o r t h e r a d i o a s s a y of Pu a n d Am i nbiological samples,"Health Phys., 51, 797 (1986).
14. Pochin, E.E."Bases for the detection and measurement of depositedradionuclides , "Diagnosis and Treatment of Deposited Radionuclides, Kornberg, H.A.and Norwood, W.D., Eds., Excerpta Medica Foundation, Amsterdam,p.127 (1968).
15. "Report cf the Task Group on Reference Man,"ICRP Publication No. 23, Pergarnon Press, New York (1975).
16. Zolotov, Yu.A. and Kuzmin, N.M."Comprehensive Analytical Chemistry xxv, Preconcentration of TraceElements," (Edited by Svehla, G.), Elsevier, Amsterdam (1990)
17. Brana, T. and Ghersini, G. (Eds.)"Extraction Chromotography," Akademiai Kiado, Budapest (1975)
IS. Ide., H.M., Mosses, W.D. and Gautier, M.A."Rapid Screening Methods for the analysis of Plutonium orAmericium in urine."Health Phys., 49, 970 (1985).
19. Butler, F.E."Determination of Uranium and Americium-Durium in Urine by LiquidIon Exchange,"
Anal. Chem., 37, 340 (1965).
20. Patti, F. and Bullier, D."Quantitative Determination of Americium in Urine,"Radioprotection, 6(2), 149 (1971).
21. Widua, L., Geosert. K. and Schieferdecker, H."Radiochemical assay in the picocurie range for Americium,Curium and Californium in Urine, Blood and Faeces,"KFK-EXT-23/76-1, 13 (1976.'.
22. Gautier, M. A."Manual of Analytical Methods for Radiobi 0assay,"LA-9763-M, R100-1 (1983).
23. Larsen R.P., Walkup, R.E. an! Oldham, R.D."Method for the Determination of Am-241 ir, Urine,"ANL-78-65 (pt.2), 153 (1978).
24. Kamath, P.R. et. al,"Recent Radiochemical Procedures for Bioassay Studies at Trombay,"IAEA Symposium on Assessment of Radioactive contamination in Man,Heidelberg, FRO, SM/52-67, 195 (1964).
2 5 . K a l a i s e l v a n , S . and P r a s a d , M.V.R."Some I m p r o v e m e n t s i n t h e E s t i m a t i o n of C s - 1 3 7 i n U r i n e by
A M P - C h l o r o s t a n n a t e M e t h o d , "j . R a d i o a n a l . Nuc l . Chem. A r t i c l e s , 1 2 5 ( 2 ) , 431 ( 1 9 8 8 ) .
2 6 . G a u t i e r , M. A."Manual of A n a l y t i c a l M e t h o d s t o r R a d i o b i o a s s a y , "LA-9763-M, R 1 2 0 - 1 ( 1 9 8 3 ) .
2 7 . D e r e c k i , J . , G e i s l e r , J . , J a n k o v i c , D. and J a w o r o w s k i , Z ." Q u i c k M e t h o d s f o r R a d i o c h e m i c a l A n a l y s i s , "IAEA T e c h . R e p o r t N o . 9 5 , p . 7 , IAEA, A u s t r i a ( 1 9 6 9 ) .
2 8 . K o p r d a , V . , S c a s n a r . V . and G a l a n , P ." S e p a r a t i o n of C s - 1 3 7 and S r - 9 0 f rom m i n e r a l i z a t e s of B i o l o g i c a lM a t e r i a l s by D i c a r b o l l i d e of C o b a l t , "J . R a d i o a n a l . C h e m . , 8 0 ( 1 - 2 ) , 55 ( 1 9 8 3 ) .
29. Naumann, M. and Ubl, G."Radiochemical Determination of Plutonium in Urine in the presenceof Complexing Agents,"J. Radioanal. Chem., 58(1-2), 341 (1980) (in German)Anal. Abstr. 40, 4D47 (1981).
30 . Veselsky, J .C."Routine Procedure for Determination of Trace Amounts of Plutoniumin urine, "Mikrochim. Acta 1(1-2), 79 (1978).
31. Weiss, H.V. and Shipman, W.H."Radiochemical Determination of Plutonium in Urine,"Anal. Chem., 33, 37 (1961).
32. Kamala Rudran, Kamath, P.R."Determination of Plutonium in Urine,"IAEA Tech. Report No. 95, p.31, IAEA, Austria (1969).
33. Schieferdecker, H."Determination of Plutonium in Urine,"IAEA Tech. Report No.95, p.29, IAEA, Austria (1969).
34. Silker, W.B."Rapid Determination of Plutonium in Urine,"Health Phys . , 11(9), 965 (1965).
35. Cautler, M. A."Manual ol Analytical Methods lor Kadi ob 1 Od L.«y , "LA - 9763 - M, R190-1 (19810 .
36. Clanet, F., Ballada, J., Lucas, J. and Gill, C."Determination of Urinary Plutonium by Radiochemical Analysis onIon exchage filters,"Health Phys., 23(2), 244 (1972).
33
3 7 . B a t s c h , J o a n n a a n d G e i s l e r , J a n" S i m p l i f i e d Method f o r D e t e r m i n a t i o n of U r i n a r y P l u t o n i u m , "Chem. A n a l . ( W a r s a w ) , 2 2 ' 6 ) , 1177 ( 1 9 7 7 ) .
3 8 . K a l a i s e l v a n , 5 . , P r a s a d , M.V.R. and J e e v a n r a m , R . K ." E s t i m a t i o n of P u - 2 3 9 i n U r i n e , I n f l u e n c e of S u l k o w i c h R e a g e n t , "J . R a d i o a n a l . a n d N u c l e a r Chem. A r t i c l e s , 1 2 5 ( 1 ) , 41 ( 1 9 8 8 ) .
3 9 . T e s t a , C ." I n d i r e c t M e t h o d s u s e d a t CNEN f o r t h e e v a l u a t i o n of I n t e r n a lC o n t a m i n a t i o n , "IAEA Symposium on " A s s e s s m e n t of R a d i o a c t i v e C o n t a m i n a t i o n i nM a n , " S M - 1 5 0 / 1 8 , 4 0 5 , S t o c k h o l m , IAEA, V i e n n a ( 1 9 7 2 ) .
4 0 . " M e t h o d s of R a d i o c h e m i c a l A n a l y s i s , "WHO T e c h . R e p o r t N o . 1 7 3 , G e n e v a , p . 1 0 4 ( 1 9 5 9 ) .
41. Holgye, Z."Determination of Plutonium in large volumes of Urine,"J. Radioanal. Chem., 54(1-2), 371 (1979).
42. Testa, C ."New Radiotoxicological Methods used at the Italian Nuclear Centreof Casaccia,"CNEN Report RT/PROT (69), 44 (1969).
43. Irlweck, K. and Streit, S."Determination of Uranium and Plutonium in Excretion Analysis,"Mikrochim Acta, II, 63 (197S).
44. Valentin, M., Weyers, C. and Boulanger, R.''Plutonium Uri nanaly si s , "3.L.G. Report 353 (1965).
45. Bellintani, S.A."Study of a dosimetric Methodology for Plutonium by means ofRadiotonological Analysis in Urine," (in Portugese),INIS-BR-1679, lllp. (1988), INIS Atom Index:2_0: 079300 (1989).
45. Gautier, M. A."Manual of Analytical Methods for Radiobioassay,"LA - 9763 - M, R170-1 (1983).
47 . Talvitie, N.A."Radicchemical Determination of Plutonium in Environmental andBiological Sa'noles by I en Exchange,"Anal. Chem., 43, 1827 (1971).
48. Campbell, E.E. and Moss W.D."Determination of Plutonium in Urine by Anion exchange,"Health Ph—j., 11, 737 (1965).
34
49. Kressin, I .K ."Separation of Plutonium in Urine without Sample ashing forDetermination by Alpha Spectrometry,"Anal. Chem., 53, 1270 (1981).
50. Sanders, S. and Leidt, S.C."A New Procedure for Plutonium Urinalysis,"Health Phys., 6, 189 (1961).
51 . Jacobsen , W. R ." I n i t i a l two year experience with the Savannah-River PlutoniumAnalysis Procedure ,"Report ANL-6637, U.S. Atomic Energy Commission (1961).
52. Eakins, J .D ."The Determination of Plutonium alpha a c t i v i t y in Urine by SurfaceAdsorption and Ion exchange,"UKAEA, Unclass i f ied Report , AERE - R5637 (1968).
52. Moorty, A.R. and Schopfer, C . J ."Measurement of At tocur ie Levels of Pu-239 in Urine using Fiss ionTrack Ana lys i s , "Anon Proceedings of the 32nd Annual Conference on Bioassay,Analyt ica l and Environmental Radiochemistry, Gai thersburg, MD(USA)(1986), INIS Atom Index: J_9: 017571 (1988)
54. Moorty, A.R., Henze, D. , Banerjee, 3 . , Sun L.C. and Meinhold, C.B."Fission Track Urine Bioassay of Pu-239,"3rd I n t e r n a t i o n a l Conference on Low-Level Measuremens of Act in idesand Long Lived Radionuclides in Biologica l and EnvironmentalSamples, p . 8 , Bombay, India (1990).
55. Jothi R. Bhaindarkar and Kamath, P.R."Determination of Radioruthenium in u r i n e , "Miciochemical Journa l , 11, 404 (1966).
56. Naumann, M. and Ubl, G."Radiochemical Determination of Ru-106 in Ur ine , "J . Radioanal . Chem., 21 , 497 (1974).
5 7. Boni, A.L."Determination of Total Radiostrontium in Biological Samplescontaining large quantities of Calcium, Selective precipitationwith Potassium Rhodizonate,"Anal. Chem., 35, 744 (1963).
58. Eakins, J .D. and Goran, P.J."A New Method for the Determination of Radiostrontium in Urine,"Health Phys., 12(11), 1557 (1966).
59. Scasnar , V ."Determination of Strontium-90 in Urine by Extract ion withoutAshing, "Anal. Chem., 56(3) , 605 (1984).
35
60. C a h i l l , D.F. and Lindsey, G . I ."Determination of Strontium-90 in Urine by Anion exchange,"Anal. Chem., 38, 639 (1966).
6 1 . Fairman, W.D. and Sedle t , J ."The Determination of l'c-99 in Ur ine , "U.S. Atomic Energy Commission Report , TID-7696, p.10 (1963).
52. Brener, F. , Delia S i t e , A. and Marchionni, V."Determinazione del Tc-99 n e l l e Urine per .la Valutazione d e l l acontaminazione i n t e r n a , "At t i del XX Congresso Nazionale d e l l a Associazione I t a l i a n a diF i s i c a S a n i t a r i a , p.307 (1977).
63. Sandro C a t t a r i n , Lucio Dore t t i and Ulderico Mazzi"Determination of Technetium-99 in Urine by Liquid S c i n t i l l a t i o nCounting to Evaluate In t e rna l Contamination,"Health Phys . , 49(5) , 795 (1985).
64. Kramer, G. H."Determination of Technetium-99 in Ur ine , "Can. J . Chem., 61 , 1949 (1983).
65. "Estimation of Th-232 in Ur ine , "in Methods of Radiochemical Analysis,Joint WHO/FAO Report, No.173, Palais Des Nations, Geneva (1959).
6 5 . Gaut i er , M. A." Manual of A n a l y t i c a l Methods for R a d i o b i o a s s a y , "LA-9763-M, R210-1 ( 1 9 8 3 ) .
67 . P r a s a d , M.V.R., K a l a i s e l v a n , S . , S u r y a n a r a y a n a , D . S . andJ eevanram, R.K."Rapid E s t i m a t i o n of N a t u r a l Thorium in U r i n e , "R a d i o c h e m i s t r y and R a d i a t i o n Chemis t ry Symposium, Nagpur, I n d i a(1930) .
6 8 . Manchuk, V .A . , P a v l o v s k a y a . N .A . , P e t u s h k o v , A .A . ,S p i r i d o n o v , B . P . and C h e r k a s h i n a , T.N." D e t e r m i n a t i o n of U-238 and Th-232 in Ur ine by Neut ron A c t i v a t i o nMethod, "Radiokhirrdya , 2 1 ( 6 ) , 905 (1979) (In R u s s i a n ) ,Anal. Abstr. 40, 4D46 (1981).
69. Pleskach, S .D ."Det ermina: t i on of Uranium and Thorium in Urine by NeutronAct ivat i or. , "Health Phys., 48, 303 (1985).
70. Bezzano, E. and Ghersini, G."A Rapid Colorimetric Method for the Determination of Thorium inHuman Urine , "Anal. Chim. Acta , 38, 457 (1967).
36
7 1 . Tuo, Kuei-Yuan, Wang, Meng-Tsai and Tung" S e p a r a t i o n and F l u o r i m e t r i c D e t e r m i n a t i o n of Uranium in U r i n e , "F e n . Hsi Hua Hsueh, 7 ( 4 ) , 285 (1979) ( in C h i n e e s e ) ,A n a l . A b s t r . 40 , 4D43 ( 1 9 8 1 ) .
72 . K r e s s i n , I . K ."Spectrophotometr:c Method for the Determination of Uranium inUrine, "Anal. Cham., 56(12), 2269 (1984).
73. Korkisch, J. and Steffan, I."Determination of Uranium in Urine Specimens after separation byAni on exchange , "Mikrochim Acta, No.2, 273 (1973).
74. Centanni , F.A., Ross, A.M. and De Sesa, H.A."Fluorimetric Determination of Uranium,"Anal. Chem., 28, 1651 (1956).
75. Gavra, Z., Lapid, J., Givra,Y. and Hemi, A."Fluorimetric Determination of Uranium in Urine followingExtraction with Aliquat-336 , "NRCN-527, 24 (1988) .
76. Gautier, M. A." M a n u a l of A n a l y t i c a l M e t h o d s f o r R a d i o b i o a s s a y , "L A - 9 7 6 3 - M , R 2 8 0 - 1 ( 1 9 8 3 ) .
7 7 . P a v l o v s k a y a , N . A . a n d M a r t a k o v a , P . I ."Simple and Selective Methods for Determining Microgram Amounts ofUranium-238 in Urine,"Radiokhimiya, 19(3), 394 (1977) (In Russian),Anal. Abstr. 34, 5D33 (1978).
78. Dupyk, I. A. and Dupzyk, R.J."Separation of Uranium from Urine for Measurement by Fluorimetry orIsotope Dilution Mass Spectrometry,"Health Phys., 36, 526 (1979).
79. May, M.F., Walker, R.L., Scott, T .G. , Dyer, F.F. andStokely, J.R."The Determination of Uranium in Urine by Isotope Dilution MassSpectrometry using resin bed loading,"Proc. of the 24th Conference on Analytical Chemistry in EnergyTechnology (Anal. Chem. Symp. Series Vol.19), New York, Elsevier,p.161 (1983).
80. Moore, L.L. and Williams, R.L."An Extremely Rapid Method for Determining Nanogram Quan t i t i e s ofUranium in Urine using the Kinet ic Phosphoresence Analyser ,"3rd In t e rna t i ona l Conference on Low-Level Measurements of Act inidesand Long Lived Radionuclides in Biological and EnvironmentalSamples, p . 3 , Bombay, India (1990).
37
81. Kelly, W. R., Fasset, J.D. and Hotes, S.A."Determining Picogram Quantities of Uranium in Human Urine byThermal Ionisation Mass Spectrometry,"Health Phys., 52, 331 (1987)
82. Duarte, C .L . and Szeles,M.S." Determination of Uranium in Urine by Alpha Spectrometry,"IPEN-PUB-258, p.24 (1989).
83. Hinton, E.R."Development of a Multipurpose Alpha-detection Procedure forEnriched Uranium in Urine,"Anal. Letters, 16(B5), 367 (1983).
84. Clanet, F. and Ballada, J."Radiochemial Analysis on Ion Exchange Filters. Determination ofUranium Isotopes in Urine,"Int. J. Appl . Radiat . Isot., 21, 147 (1970).
85 . Levin, L."Liquid Scintillation Method for Measuring Low Level Radioactivityof aqueous solutions. Determination of Enriched Uranium in Urine,"Anal. Chem., 34, 1402 (1962).
86. Brits, R.J.N. and Holemans, E .A."Determination of Uranium in Urine by Delayed Neutron Counting,"Health Phys., 36(1), 65 (1979).
87. Gautier, M.A."Manual of Analytical Methods for Radiobioassay,"LA-9763-M, R260-1 (1983).
85. Currie, L.A., France, G.M. and Mullar, P.A."Radiochemical Determination of Uranium of Low Activity,"Health Phys., 10, 751 (1964).
89. Henley, L.C."Urinanalys is by Ion exchange,"11th Annu. Bio-Assay anr1 Analyt ical Chemistry Conference,Albuquerqua, N.M. (1965).
90. Iyer , R . 3 . and Kamath P.R."Separation of Bismuth Phosphate-Carried Actinoids by BismuthOxychloride P r e c i p i t a t i o n , 1 'Mikrochem J . , 17, 105 (1972).
91 . Buttler, F.E."Rapid Bio-assay Methods for Detn. of Plutonium, Neptunium andUranium in Urine,"Health Phys., 15, 92^ (1967).
92. Kramer, G.H. and Davies , Janet M." I s o l a t i o n of S r -90 , Y-SO, Pm-147 and Ce-144 from wet ashed Urineby Calcium Oxala te C o - p r e c i p i t a t i o n and Sequen t i a l SolventE x t r a c t i o n , "Anal . Chem., 5 4 ( 8 ) , 1428 (1982)
93 . Horwi tz , E . P . , D i e t z , M.L., Nelson, D.M., LaRosa, J . J . andFai rman,W.D."Concen t ra t ion and Separa t ion of A c t i n i d e s from Urine us ing asupported B i f u n c t i o n a l Organophosphorus E x t r a c t a n t , "Anal . Chim. Acta , 238, 263 (1990) .
94. G iacc rne l l i , R. and Spezzano, P ."Separa t ion and Sequen t i a l De te rmina t ion of Americium and Plutoniumin Urine Samples , "Inorg. Chim. Acta, 94(5), 223 (1984).
95. Veselsky, J,C., Pak Chan Kirl and Sezginer, N."The Determination of Uranium, Neptunium and Plutonium in Urine bySequential Extraction with Alamine - 336 from Hydrochloric Acidmedium,"J. Radioanal. Chem., 21, 97 (1974).
9 5. D e 11 e S i t e , A."Ana ly t i c a l A p p l i c a t i o n s of Neotr idecanohydroxymin Acid ass t a t i o n a r y phase in E x t r a c t i o n Chromatography,"J . R a d i o a n a l . Chem., 14, 45 (1973) .
39
TABLE 1
The following Table 1 summarises the bioassay procedures
reported upto 1990. The radionuclides are tabulated in the
alphabetical order and are arranged in the increasing order of
sensitivity of the method. The details furnished here are to the
best of our knowledge and the availability of literature in our
library at Indira Gandhi Centre for Atomic Research, Kalpakkam.
This table gives an opportunity to the reader to select a
suitable method by considering the sensitivity, recovery and
sequential determination either to standardise a particular
procedure or to further improve the methodology. Based on
analysis time, recovery percentage and sensitivity, the following
remarks were made in the Table 1. Screening and rapid methods
takes 30 minutes to 4 hours; Simple method takes half a day to
one full day; Satisfactory method takes one and half to 2 days;
tedious method involves many number of steps and takes more than
3 days; time consuming method takes D 3 0 days time. Poor recovery
indicates <70% ; satisfactory recovery indicates 70-90% and good
recovery indicates >90%. Minimum detection limit of a poor
3 3sensitive method is >10 mBq/dm ; sensitive method is ^1 mBq/dm
3and that of highly sensitive method is around 0.1 mBq/dm . Poor
precision indicates a precision range >10%.
4 0
Abb revia t i on s :
Preconcn.: Preconcent ra t ion ; Ref.: Reference; Solv. E x t r n . :
Solvent Ex t r ac t ion ; An. Exng. : Anion Exchange; Ct . Excng.: Cation
Exchange; E lec . Depsn.: E lec t ro Deposi t ion; TPAC: Tetra Phenyl
Arsonium Chlor ide; MEK : Methyl Ethyl Ketone; TTA : Theonyl
Tr i f luo ro Acetone; TIOA: Tri Iso-Octyl Amine; MIBK: Methyl I so -
butyl Ketone; TOPO : Tr i -n-Octyl Phosphine Oxide; TOA: Tri Octyl
Amine; KEL-F: Poly t r i f l u o r o c h l o r o e t h y l e n e ; HX 7 0 :
N'eot ridecanohydroxamin Acid .
Co-precipi ta t ions with: Sulkowich reagent; Alkaline Earth
Phosphate; cOxalate; Lanthanum Fluoride; e Fer r ic Hydroxide;
'Copper Sulfide; ^Ceric lodate; 'Potassium Aluminum Sulphate.
Extraction Chronat ograp'ny column containing: 1 . 5g of 50-
100 mesh Microthene-710 supporting 1.5 ml of 0.5M TOPO in
cyclohexane; 50% mixture of TOA and xylene on a KEL-F support;
CMicrolhene-HDEHP in toluene; d Microthene-HX 70.
41
Table 1: Preconcentration methods, analytical techniques, sensitivityand recovery of bioassay methods of various radionuclides in urine.
SI .No .
1
2
3
4
5
6
7
S
9
.1.0
11
Radio-n u c l i d e
Am-241
-do-
-do -
-do-
-do -
-do -
-do -
Cs-137
-do-
-do-
-do -
Preconcn .method
- -
aCo-pptn .
Wet Ashing,E x t r n . withHDEHP,E l e c . Depsn.
C o - p p t n . ,An . Exng . ,C o - p p t n . ,Ct . Exng .
Dry Ashing,Solv . Ext rn .with TOPO,E l e c . Dep sn .
Co-pptn . ,C t . Exng . ,E l e c . Dep sn .
Wet Ashing,El ec . Dt>psn.
Adsorp t i onon AMP,Ct . Exng .
Adsorpt i onon AMP.,Ct . i-'.xng .
Techniqueused
Direc t Count-i n g , PhoswichDet ect or
Alpha Counting
Alpha Counting
AlphaSpect romet ry
AlphaSpect romet ry
AlphaSpect romet ry
I sol opi c Diln.Alpha Spectre-met ry
Beta Counting
y-Count ing withMarine!li beaker
-do-
Low Be.taCount ing
Sens i t iv i ty ,(m Bq/dm )
(Recovery,%)
3*103
37
20(89^6%)
3 . 7
1 .8
(66_+12%)
0.8(9 5^7%)
0.143(80-90%)
(80%)
4.6*10 3
(104j+3%)
3.7*10 3
l . l * 1 0 3
(100+_3%)
Remarks
Screeningmethod
Screeningmethod
Satisfa-ctorymethod
Tedious
Poorrecovery
Sensitivemethod
Highlysensitivemethod
Satisfa-ctoryrecovery
Rapidmethod
-do-
Goodrecovery
Ref
18
18
19
20
21
22
23
24
25
26
25
42
SINo
12
1 3
14
1 5
16
17
18
19
20
21
R a d i o -nuclide
Cs-137
-do-
Plut onium
-do-
Pu-239Pu-238
P lut onium
-do-
-do-
-do-
-do-
Preconcn.method
Adsorpt i onon AMP Mats
Extrn. withdi ca rbo l l ideof CobaltAn . Exng.
Co-pptn.,Extrn. withAlamine-336,Elec . Depsn.
Co-pptn.,An . Exng.El ec . Depsn .
— — —
Rh odi zonat eCrys ta l1 i za-t i o n , d
Cc-pptn . ,An . exng. ,El ec . Depsn .
Co -pptn. ,TTA Extrn . ,El h?c . Depsn .
High Temp.A i . Exng .Batch Process
Co-pptn.
Co-pptn.
Techniqueused
Low BetaCount ing
Low BetaCount ing
Alpha Counting
AlphaSpect romet ry
Direct Count-ing PhoswichDet ector
Alpha Counting
Alpha Counting
AlphaSpect romet ry
Alpha Counting
Alpha Counting
Sensi t i v i t y ,(m Bq/dm )
(Recovery,% )
3 7
IS(97%)
(70%)
(90%)
64*10!?32*10
l * 1 0 3
(91+.5%)
740( 4 5% )
67(84S)
6 0
37
Remarks
Poor sen-s i t iv i ty
Goodrecovery.
Poorrecovery
Satisfa-ct oryrecovery
Screeningmethod
Ref .
2 7
2 8
2 9
3 0
1 8
Good 31recoveryRequi reslarge volumesof AbsoluteAlcohol
Rapid, butpoorrecovery
Screeningmethod
-do-
Screening
3 3
3 4
3 5
1 8
-do- Co-pptn.,' Alpha Counting 37An. Exng. (8 0^8%)resin f i11 er s
method
S i mp1emethod
36
4 °'
SI . Radi o-nuclide
Preconen .method
Techniqueused
Sensi t ivi ty , Remarks Ref(m Bq/dm )
(Recovery,%)
23 Pu-239 Co-pptn.
24 -do- Co-pptn . '
Liq. Scintilla- 35tion Counting. (100^20%)
Alpha Counting 13
S i mp1emethod,Poorpreci sion
Simplemethod
37
38
25
26
J. i
-do-
-dc-
Extrn. Chro- Alpha counting 11mat ography"
Co-pptn . ,Ext rn . wi t hCupf erron ,Co-pptn .
Pu-239 Co-pptns . ,Ext rn . wi thTTA
b,d
Alpha Counting
Alpha Counting
-do- '.Vet Ashing,Co-pptn . ,Ext rn . Chrp-mat og raphy
2 9 Plutonium Co-pptn.,An . Exng . ,Elec . Dep sn
3 0 Pu-2 39 Co-pptn.,An . Exng. ,El p • . [)ep sn .
31 -do- Wei Ashing,Co-pptn . ,TTA Ext rn . ,Ei ec. Depsn .
3 2 Plutonium Co-pptn.,An. Exng . ,Rlec. Dep sn .
3 3 -do- i..o-pptn. ,'An . Exng .
AlphaSpf ct romet ry
Low backgroundSolid State'Jet ect or
Alph-aSpect romet ry
AlphaSpect romet ry
AlpliaSpeciromet ry
(77%)
7.4(90%)
3.7
Alpha Counting 1.7(90+2%)
1 .3(95%)
1 . 1( 7 8% )
1 . 1(85%)
0.8(95+7%
0 .74(91%)
Satisfa-ct oryrecovery
Goodrecovery
39
40
Useful for 41largesamples
Satisfa- 42ct orymethod
Sequen- 43tial U &Pu Detn.
Sensitive 44method/Timeconsuming
Sensitive 45method
Goodrecovery
Goodrecovery
46
47
4 4
Si .No .
34
3 5
3 5
37
Radi o-nucl ide
Plut onium
-do-
-do-
-do-
Preconcn.method
Co-pptn . ,An . Exng . ,Elec . Depsn .
Co-pptn . ,An . Exng . ,HIec . Depsn .
Wet Ashing,An . Exng . ,Elec . Dep sn .
bCo-pptn . ,Ad sorpt i on on
Techniqueused
Nuclear TrackAnalysi s.
AlphaSpect romet ry
Nuclear TrackCount ing
Alpha Counting
Sensi t i v i t y ,(m Bq/dm )
(Recovery, %)
0 .6(84^14%)
0 55
0 .5(53_+25%)
0.37(89+4%)
Remarks
Time con-suming
Sensitivemethod
Poorrecovery,Time con-suming
Sensit ivemethod
Ref .
48
49
50,51
52
3 8
3 9
4 0
4 1
42
4 3
Pu-239
Radio-ruthe-nium
Ru-106
Radi oSt ron-t ium.
-do-
Sr-90
Glass Fibrefilter paper,An . Exng.,Elec. Depsn.
Wet Ashing,An . Exngs.
Fission TrackAnalysi s.
KMnO Oxdn . , Beta CountingRedn. ofRuO, to metal4
Wet ashing, Beta CountingPermanganate and Spect ropho-Oxdn., Redn. tometryof RuO. to Ru4
Ct. Exng., Beta CountingCo-pptn withRhodi zonate.Co-pptns. '
Co-pptn . asSt rontiumSulphat e
Beta Counting
Extrn. with Liq Scintilla-Dicarbollide tion Countingacid
2.1*10-3
(78+5%)
(69%)
(76+12%)
(80%)
3.7*10%
Highly 53,Sensitive 54method/Timeconsuming
Satisfa- 55ct orymethod
Poorrecovery
Tedious
56
57
Satisfa-ctoryrecovery
Rapidmethod
58
59
45
SI. Radio- Preconcn. TechniqueNo. nuclide method used
Sens i t iv i ty , Remarks Ref(m Bq/dm )
(Recovery,%)
44 Sr-90 Extrn. Chro- Beta Counting 130matography,C of Y-90 (92%)Co-pptn .
Rapidmethod
39
4o -do- An. Exng . ,Co-pptn .
Beta Countingof Y-90
74(65+10%)
Takes 14 d 60for growthof Y-90.
4 6 -do- Extrn. with Low Betadicarbol l ide Countingof Cobalt .
19(94%)
Goodrecovery
28
4 7 T c-9 9 Ammonia Sea- Beta Countingvenging potn.Co-pptn . ,Ct . Exng . ,Ext rn . withTPAC .
(50-65%) Poorrecovery
61
48 -do-
4S
5 0
53
-do-
-do-
-do-
-do-
-do-
Co-pptn.with TPAC
Co-pptn . ,Ct . Exng . ,Extrn. withMEK
Co-pptn . ,TTA E x t r n .
Co-pptn . ,Extrn. withCupferron andAshing
Co-pptn . ,An. Exng .
Beta Counting
Liq . Scint i1 la -tion Counting
Beta Counting
Spect rophot ca-me t ry withThoronol
Spect rophot o-metry withThoronol
Spect rophot o-metry withArsenazo(I I I )
(72^5%)
1.4*103
(97+2%)
100(81%)
(75%)
102(96^10%)
82(95+3%)
Satisfa-ct oryrecovery
Rapidmethod,Goodrecovery
Satisfa-ct orymethod
Sati sfa-ctoryrecovery
Poor sensitivity
Poor sensitivity
62
63
64
24
65
- 66
46
SI .N o .
54
5 5
5 6
5 7
Radi o-nuclide
NaturalThorium
Th-232
-do-
NaturalThorium
Preconen.method
Co-pptns.b > g
An . Exng.
Co-pptn.,Ashing, Ad-sorption onSi l ica Gel
Co-pptn . b ' h
Techniqueused
Spect rophot o-metry withThoronol
Neutron Activa-tion Analysi s.
Neutron Activa-t ion Analysis
Spect rophot o-metry withArsenazo(III)
Sensi t iv i ty(m Bq/dm )
(Recovery,%
6 6(80+6%)
4 1
4 . 1(80+10%)
2 . 5
, R ema rk s
)
Satisfa-ctorymethod
Tedious
Tedious
Simplemethod
Ref
6 7
6 8
6 9
7 0
58 -do-
59 NaturalUranium
60 -do-
61
62
63
-do-
U-238
-do-
Extrn. Chro- Spectrophoto-matography metry with
Arsenazo(III)
Adsorption of Fused pelletU-ArsenazoIII Fluorimetrycomplex onActivatedCarbon, De-sorption withSod .Carbo-nat e, Ext rn .with Chloro-phosponazonat e
An . Exng.
An . Exng.
Spect rophot o-metry withArsenazolIII)
Fluorimet ry
Co-pptn., Neutron Activa-Adsorption on tion AnalysisSilica Gel
An . Exng. Neutron Activa-tion Analysis
0.41(98%)
630(B7%-94%)
Rapid & 42Sensi tivemethod
Tedious
5 0 0(83^
>250
1 5 0(8 0+
1 2 5
8%)
20%)
Poor sen-sitivity
Poor sen-sitivity.
Tedious
Tedious
71
72
73
69
68
47
SI .No .
64
65
66
67
58
Radi o-nuc l ide
NaturalUranium
-do-
-do-
-do-
-do-
Preconcn.method
Ex t rn . withAl iquat -336
Co-pp tn . ,Ex t rn . withTIOA
Co-pptn. asMethyl Vio le tThi ocyanat e
Dry Ashing,Ext rn . withMIBK
Techniqueused
Fluorimet ry
Fluorimet ry
Fused pelletFluorimetry
Spect rophot o-metry withArsenazo(III)
Fused PelletFluorimet ry
Sensit iv i ty ,(m Bq/dm )
(Recovery,%)
50
25(100^10%)
25(100^4%)
25
7 . 5
Remarks
Pooi i>en-s i t :v i ty
Poor sen-sitivity
Goodr e c ov e ry
Poor sen-sitivity
Satisfa-ct orymethod
Ref
74
75
76
77
43
69 -do- An . Exng .
70
71
72
73
74
-do-
-do-
-do~
U-235
-do-
Ion Exng .
Wet Ashing
Wet Ashing,An . Exng .
An . Exng.,Membrane Sep-ara t ion withTOPO layer
An . Exng . ,Extrn. withHDEHP .
Fused P e l l e tFluor imetry ,Isotope Dilu-t ion Ma s sSpect romet ry
Isotope Dilu-t i on Ma s sSpect romet ry
Pulsed LaserE x c i t a t i on,Kinet ic Phos-phorescenceana lys i s
Thermal Ionisa-t i on Ma s sSpect romet ry
AlphaSpect romet ry
AlphaSpect romet ry
2.5 Satisfa-(75^5%)(FL) ctory(95^1%) recovery(ISDM)
78
2 .5
1 .5
77*10- 3
(85%)
1 .5*10'(92 %)
Satisfa- 79ct orymethod
Sensitive 80method
Highlysensi t ivemethod
Poor Sen-sitivity
81
Satisfa- 82ctoryrecovery
83
48
SI .Nc .
75
76
77
78
79
80
81
82
83
84
85
Radio -nuclide
U-235
-do-
-do-
-do-
-do-
-do-
-do-
Am-241,Cm-242,Cf-244.
U, Pu,Np, Pa
Th, Pu
Pu, Npand U
Preconen.method
An . Exng.on filters
Dry Ashing,An . Exng.
An.Exng,of U-Thiocyanat e,Irradiat i onof the resin
An . Exng .
Extrn. Chro-matography
Wet ashingExtrn. withTIOA
An . Exng.
Dry Ashing,Solv. Extrn.with TOPO,Elec. Depsn.
Co-pptn . ,An . Exng .
-do-
Wet ashing,Extrn. withTIOA
Techniqueused
Alpha Counting
L ow T emp. L i q•ScintillationCounting.
Delayed NeutronCounting.
Alpha Counting
Alpha Counting
Alpha Counting
Alpha Counting
AlphaSpect rometry
-do-
Alpha Counting
Alpha Counting
Sensitivity,(m Bq/dm )
(Recovery)
500(100+_30%)
300
82(80+_13%)
37(83^10%)
34(70%)
18(84^10%)
5.4(96+^3%)
1.8
(66_+12%)
11
Remarks
Poor Sen-sitivity
Poor Sen-sitivity
Poorprecision
Poor sen-sitivity
-do-
Poorpreci sion
Sensitivemethod
Poorrecovery
Sequen-tial detn.
-do-
-do-
Ref
84
85
86
87
42
19
88
21
89
90
91
49
SI .No.
86
87
88
89
SO
Radi o-nuclide
Sr-90,Y-90,Ce-144,Pm-147
U-236,Np-2.37,Pu-239
Am andPu
U, Npand Pu
Np-237,Pu-239
Precon en .method
Co-pptn . ,Extrn. withHDEHP,Co-pptn .C
Co-pptn . ,Exng. onCMPO-TBP-Amberlit eXAD -7
Ext rn . wi thDibutyl di-ethyl carba-moyl Phos-phonat e
Co-pptn . ,Ext rn . wi thAlamine-3 36
Co-pptn . ,Extrn Chro-matographyEl ec . Depsn .
Techniqueused
Low BetaCounting
High ResolutionAlphaSpect romet ry
Alpha Counting
-do-
Alpha Counting
Sensit ivity,(m Bq/dm )
(Recovery,%)
44 (100%)52 (65%)60 (87%)74 (90%)
> (90%)
(80%)(68%)
> (95%)
16(82+4%)(Np)5(73+3%)(Pu)
R ema rk s
Sequen-tial Detn
Sequen-tial &Rapidmethod
Sequen-tial Detn
-do-
-do-
Ref
92
93
94
95
96
50
Table:2 Details of Instrumentation generally used in Bioassay Programme
Counting Nuclides Nature of Background/System detected detector (Sensitivity)
Effici- Sampleency(%) preparation
«C-Count ing
a) Scint i -l la t ion
b ) LiquidScint i -l la t ion
c) AlphaSpectro-met er
d) NuclearTrackCounting
e) FissionTrackCounting
/-Count ing
a)LiquidScint i -l la t ion
b)Low BetaCounter
Gamma #Counting—
Spect ro~phot omet er
Fluori-met er
All alphaemitters
All alphaemi 11 ers
All alphaemit ters
Plut onium
Plut onium
Low energyB-emi 11 ers
All betaemit te rs
All gammaemi 11 ers
NaturalThorium,NaturalUranium
Uranium
ZnS (Ag)
PPO$
(in Dioxane)
Surfacebarri er[Si(Li)]
Solid Statetrack dete-ctor
SyntheticfusedSilica
PPO$
(in Dioxane)
GeigerMu 11 e r
Nal ( T l )
HPGe
_ _ «.
r* 0 . 08 cpm
<1 cpm
( 0 . 5 5 mBq/1)
( 0 . 1 mBq/1)
( 0 . 0 0 2 mBq/1)
7 cpm
1-2 cpm
- -
— —
(ug/ml)#
(ng/ml)#
20-30
100
,-v2
17
30-40
10-40
20-40
<5
• • •
• • •
Planchetting
Mixing thesample withcocktail
Electro-depositedplanchet
Exposure tocellulosenitrate film
Sample irra-diation in Th.neutron flux
Mixing thesample withwith cocktail
Planchetting
Planchetting/direct count-i n g
Measuringabsorbance ofmetal-reagentcomplex
Fusing withflux/Mixingliq. samplewith std.reagent
&PPO : Diphenyl oxazole, :energy emitters is possible, Sensitivity depends on the reagent blank.
Simultaneous determination of different
51
TABLE 3. ANNUAL LIMITS ON INTAKE, DERIVED INVESTIGATION LEVELS ANDDERIVED RECORDING LEVELS FOR SOME RADIONUCLIDES AS PER ICRP 54 (1988)
DAILY URINARY EXCRETION (mBq)
ANNUAL LIMIT DERIVED DERIVEDRADIO- ON INTAKE INVESTIGATION RECORDINGNUCLIDE (ALI, Bq) LEVEL LEVEL REPORTED METHOD OF
INHALATION DETECTION ANALYSISRoutine Moni- Routine LIMITStoring (after Monitoring180 d intake) (DIL/3)
Am-241 2*102(W)a N.A. -- 0.20 IDASd'23
c c c 7ftC s - 1 3 7 6 * 1 0 (W) 1 . 4 * 1 0 4 . 6 * 1 0 2 6 . 6 p - C o u n t i n g
P u - 2 3 9 2 * 1 0 2 ( W ) 0 . 4 1 0 . 1 4 0 . 0 0 3 } F i s s i o n
2 b -2 } T r a c k 54
P u - 2 3 9 6 * 1 0 ( Y ) 0 . 0 6 6 2 . 2 * 1 0 0 . 0 0 3 } A n a l y s i s
R u - 1 0 6 4 * 1 0 5 ( Y ) N . A . C p - C o u n t i n g 5 6
5 r - 9 0 1 * 1 0 ( Y ) 3 4 0 1 1 3 2 6 . 6 B - C o u n t i n g
T h - 2 3 2 4 0 ( W ) 0 . 3 1 0 . 1 0 0 . 5 7 } S p e c t r o - 4 £
} p h o t o m e t r yT h - 2 3 2 1 0 0 ( Y ) 0 . 0 4 7 1 . 6 * 1 0 0 . 5 7 }
U - 2 3 5 2 * 1 0 3 ( Y ) 4 . 3 1 . 4 7 . 5 6 S C S ' 8 8
T f 81
U - 2 3 8 2 * 1 0 ( Y ) 4 . 6 1 . 5 0 . 1 1 TIMS '
N.A.: Not Applicable, these monitoring intervals do not satisfy the
accuracy c r i t e r i o n . aW: Week Class; Y: Year Class; CDetection Limit not
reported; IDAS: Isotope Dilution Alpha Spectrometry; SC: Scintillation
Counting; TIMS: Thermal lonisation Mass Spectrometry.